« Back to Record
Citation APA

Bernardino, J. I., Mocroft, A., Mallon, P. W., Wallet, C., Gerstoft, J., Russell, C., Reiss, P., Katlama, C., De Wit, S., Richert, L., Babiker, A., Buño, A., Castagna, A., Girard, P. M., Chêne, G., Raffi, F., Arribas Lopez, J. R., & NEAT001/ANRS143 Study Group, (2015). Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial. The lancet. HIV, 2(11), e464-e473. doi:10.1016/S2352-3018(15)00181-2


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/224474

Bernardino, J. I., Mocroft, A., Mallon, P. W., Wallet, C., Gerstoft, J., Russell, C., Reiss, P., Katlama, C., De Wit, S., Richert, L., Babiker, A., Buño, A., Castagna, A., Girard, P. M., Chêne, G., Raffi, F., Arribas Lopez, J. R., & NEAT001/ANRS143 Study Group, (2015). Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial. The lancet. HIV, 2(11), e464-e473. doi:10.1016/S2352-3018(15)00181-2